Document is current

Any future updates will be listed below

The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation

Crossref DOI link: https://doi.org/10.1038/s41391-017-0014-9

Published Online: 2017-12-20

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark